20 LATEST RESOURCES (516 INDEXED)
Donepezil for Dementia with Lewy Bodies: Meta-Analysis of Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase II, III, and, IV Studies · March 2024
Articles
Psychogeriatrics
Lithium Management of Periodic Mood Fluctuations in Behavioural Frontotemporal Dementia: A Case Report · January 2024
Articles
Frontiers in Psychiatry
Rapamycin Responds to Alzheimer’s Disease: A Potential Translational Therapy · October 2023
Articles
Clinical Interventions in Aging
Dementia Risk of Direct Oral Anticoagulants versus Warfarin for Atrial Fibrillation: Systematic Review and Meta-Analysis · September 2023
Articles
JACC: Asia
Hydroxytyrosol–Donepezil Hybrids Play a Protective Role in an In Vitro Induced Alzheimer’s Disease Model and in Neuronal Differentiated Human SH-SY5Y Neuroblastoma Cells · August 2023
Articles
International Journal of Molecular Sciences
Effectiveness of Vortioxetine in Patients with Major Depressive Disorder and Early-Stage Dementia: The MEMORY Study · June 2023
Articles
Journal of Affective Disorders
The Association between Gabapentin or Pregabalin Use and the Risk of Dementia: An Analysis of the National Health Insurance Research Database in Taiwan · May 2023
Articles
Frontiers in Pharmacology
Safety and Efficacy of Lecanemab for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials · May 2023
Articles
Frontiers in Aging Neuroscience
Pioglitazone Use and Reduced Risk of Dementia in Patients with Diabetes Mellitus with a History of Ischemic Stroke · April 2023
Articles
NCBI>Neurology
Pioglitazone Use Increases Risk of Alzheimer’s Disease in Patients with Type 2 Diabetes Receiving Insulin · April 2023
Articles
Scientific Reports
Lecanemab for Patients with Early Alzheimer Disease: Bayesian Analysis of a Phase 2b Dose-Finding Randomized Clinical Trial · April 2023
Articles
JAMA Network Open
Extemporaneous Combination of Donepezil and Memantine to Treat Dementia in Alzheimer Disease: Evidence from Italian Real-World Data · March 2023
Articles
Current Medical Research and Opinion
Hydroxychloroquine Lowers Alzheimer’s Disease and Related Dementias Risk and Rescues Molecular Phenotypes Related to Alzheimer’s Disease · December 2022
Articles
Molecular Psychiatry
Donanemab for Alzheimer’s Disease: A Systematic Review of Clinical Trials · December 2022
Articles
Healthcare
Causal Inference in Medical Records and Complementary Systems Pharmacology for Metformin Drug Repurposing Towards Dementia · December 2022
Articles
Nature Communications
Anti-Dementia Drug Persistence Following Donepezil Initiation among Alzheimer’s Disease Patients in Japan: LIFE Study · November 2022
Articles
Journal of Alzheimer’s Disease
Modulation of Amyloid-B and Tau in Alzheimer’s Disease Plasma Neuronal-Derived Extracellular Vesicles by Cerebrolysin and Donepezil · November 2022
Articles
Journal of Alzheimer’s Disease
Evaluation of Dose-Dependent Treatment Effects After Mid-Trial Dose Escalation in Biomarker, Clinical, and Cognitive Outcomes for Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer’s Disease · November 2022
Articles
Alzheimer’s and Dementia: Diagnosis, Assessment and Disease Monitoring
Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil · October 2022
Articles
Journal of Alzheimer’s Disease